Zevra Therapeutics Inc. (ZVRA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Zevra Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.31
+2.54% today
Market cap
$597M
Overall quality
—
Kronos AI 30-day
+9.9%
7 of 8 simulated paths end higher
Zevra Therapeutics Inc. (ZVRA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $597M. It trades at $10.31, up 2.54% today. 9 analysts' average target of $25.25 implies +144.9% from today's price. Kronos AI's 30-day forecast is +9.9% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $25.25 |
| Low – high | $20.00 – $35.00 |
| Analysts | 9 |
| Upside to average | +144.9% |
Kronos AI 30-day forecast
| Expected close | $11.05 (+9.9%) |
| Likely range | +3.2% … +21.0% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.